Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

NICE refuses cancer drugs Arzerra, Torisel and Levact

October 27, 2010
Sales and Marketing Arzerra, GSK, NICE, Napp Pharmaceuticals, Pfizer, Torisel, Treanda, cancer drugs

NICE has refused to recommend a trio of cancer drugs for NHS use – but in two cases says this …

News

GSK cleared of unethical practices by PMCPA

October 22, 2010
Medical Communications ABPI, ABPI Code of Practice, Avamys, GSK, GlaxoSmithKline, PMCPA, Rupafin, Seretide

GlaxoSmithKline has been found guilty of two transgressions of the ABPI Code of Practice in a case centring on the …

News
GlaxoSmitKline's headquarters

Revenue slump for GSK as Avandia sales stall

October 22, 2010
Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results

GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …

News

GSK’s leukaemia drug rejected by NICE

September 16, 2010
Sales and Marketing Arzerra, GSK, NHS, NICE

GSK’s leukaemia treatment Arzerra has been rejected by NICE, which says the drug does not represent good value for the …

News

Avandia letter misleading, FDA tells Glaxo

August 24, 2010
Sales and Marketing Avandia, GSK

GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …

News
PakistanFloodWEB

Pharma provides aid for Pakistan

August 24, 2010
Sales and Marketing GSK, NGO, Novartis, Pakistan, disaster, pharma, relief

 The pharma industry is providing donations to help those affected by the mass flooding across Pakistan. As many as 20 …

News

GSK shingles vaccine enters late stage trials

August 23, 2010
Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …

News

Benlysta to be fast-tracked by FDA

August 20, 2010
Sales and Marketing Benlysta, GSK, HGS, Lupus

 New lupus drug Benlysta has been given priority review status by the FDA.Benlysta (belimumab) has been developed by Human Genome …

News
StemCellPinheadWeb

Regenerative medicine: small steps towards the great leap forward

August 16, 2010
Research and Development GSK, Pfizer, Stem cells, regenerative medicine

Susan Aldridge reports on what some of the leading pharma companies are doing in the regenerative medicine and stem cells …

Feature

German patent setback for GlaxoSmithKline’s Seretide

May 21, 2010
Sales and Marketing GSK, Germany, Seretide

A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …

News

FDA backs rotavirus vaccine despite contamination

May 13, 2010
Sales and Marketing GSK, Rotavirus, Vaccine, drug safety, rotarix

FDA advisors have recommended two rotavirus vaccines licensed in the US should continue to be used, despite contamination with a …

News
Patrick-Vallance

GSK appoints Patrick Vallance

May 12, 2010
Research and Development GSK, appointment, research and development

Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of …

Appointment

GSK bolsters presence in South Korea

May 11, 2010
Sales and Marketing Dong-A, GSK, Korea, em

GlaxoSmithKline has followed through with plans to expand into emerging markets by striking a co-marketing deal with South Korea’s largest …

News

Asia and emerging markets boost GSK results

April 28, 2010
Sales and Marketing GSK

Asia and emerging markets boost GlaxoSmithKline results GlaxoSmithKline has seen a jump in pharma sales due to major growth in …

News

Secondary endpoints failure take shine off Benlysta

April 21, 2010
Sales and Marketing GSK, HGS, Lupus

GlaxoSmithKline’s lupus treatment has failed to reach a statistically significant secondary endpoint in the second of two phase III trials. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025